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Abstract  
Background: The early treatment of rheumatoid arthritis (RA) is vital. However, people often 
delay in seeking help at symptom onset. An assessment of the reasons behind patient delay 
is necessary to develop interventions to promote rapid consultation.  
Objective: Using a mixed methods design we aimed to develop and test a questionnaire to 
assess the barriers to help seeking at RA onset.     
Design: Questionnaire items were extracted from previous qualitative studies. Fifteen 
people with a lived experience of arthritis participated in focus groups to enhance the 
questionnaire’s face validity. The questionnaire was also reviewed by groups of 
multidisciplinary healthcare professionals. A test-retest survey of 41 patients with newly 
presenting RA or unclassified arthritis assessed the questionnaire items’ intraclass 
correlations.  
Results: During focus groups, participants rephrased questions, added questions and 
deleted items not relevant to the questionnaire’s aims. Participants organised items into 
themes: early symptom experience, initial reactions to symptoms, self-management 
behaviours, causal beliefs, involvement of significant others, pre-diagnosis knowledge about 
RA, direct barriers to seeking help and relationship with GP. The test-retest survey identified 
seven items (out of 79) with low intraclass correlations which were removed from the final 
questionnaire. 
Conclusion: The involvement of people with a lived experience of arthritis and 
multidisciplinary healthcare professionals in the preliminary validation of the DELAY (Delays 
in EvaLuating Arthritis earlY) questionnaire has enriched its development. Preliminary 
assessment established its reliability. The DELAY questionnaire provides a tool for 
researchers to evaluate individual, cultural and health service barriers to help-seeking 
behaviour at RA onset.   
  
Background 
Irreversible joint damage occurs during the early stages of rheumatoid arthritis (RA). The first 
three months following clinical disease onset represent a therapeutic window during which 
drug treatment is particularly effective at controlling synovitis and limiting subsequent 
damage to bone and cartilage.(1-4) Despite increased recognition of the benefits of early 
treatment there remains considerable delay between symptom onset and the initiation of 
therapy.(5-7) Delays can occur at several levels including delay on the part of the patient in 
seeking medical advice at symptom onset, delay in obtaining an appointment with a primary 
healthcare professional and delays in referral to a rheumatologist, diagnosis and 
commencement of disease modifying therapy.(8;9) The median delay between symptom 
onset and assessment by a Rheumatologist in the UK has been reported to be 23 weeks, most 
of which was due to patient delay in seeking help (median 12 weeks).(7;10) Similar delays 
occur in many other European countries.(11;12) Many patients thus miss a potential 
therapeutic window because they delay in seeking help for their symptoms.  
 
Qualitative studies and a meta-synthesis have identified barriers to help seeking at the 
onset of RA.(13-16) Barriers to early consultation included the insidious onset of symptoms 
which often characterise the onset of RA. Patients often normalised their symptoms and did 
not consider arthritis as a potential cause. Pre-existing ideas about RA, often termed 
prototypical illness beliefs (cultural understandings of an illness held by people without 
personal experience of the illness in question), led people to believe that RA was a mild 
condition that affected older people. These misperceptions made correct symptom 
interpretation unlikely. Prototypes for some illnesses are better formed than those of 
others, but generally they influence individuals’ perspectives on an illness’ likely duration, its 
symptomatology, severity and consequences and the need for treatment.(17;18) These 
prototypical models can be unhelpful if they are inaccurate, and may mislead people into 
believing that the symptoms of conditions such as RA do not require them to seek medical 
attention.      
 
In addition to symptom experience, the influence of advice from family and friends, a 
frequent desire to use alterative medicines, access to health services and attitudes towards 
healthcare professionals, particularly general practitioners, are also important determinants 
of help seeking behaviour.(15;19) Further research is needed to understand the importance 
of the range of barriers to seeking help identified through qualitative research and which 
barriers are relevant to different groups within the population. A method of systematically 
measuring barriers to seeking help at the onset of RA is thus required. A tool to measure 
barriers would allow the relationship between determinants and extents of delay in help 
seeking to be assessed. A cross-sectional survey using this tool would provide an evidence 
base from which tailored interventions to promote rapid help-seeking could be developed.  
 
Exploring the perspectives of people with a lived experience of RA has been instrumental in 
determining the research priorities for people with RA and the development of appropriate 
measurement tools used to assess RA.(20-23) Furthermore, involving patients in 
questionnaire development can ensure that the questions used are appropriate, relevant and 
comprehensible to the target population.(24;25) The use of qualitative methods to explore 
themes discussed in the questionnaire can help identify salient attitudes and norms, inform 
the content, format and layout of a measurement tool and provide information about user-
friendliness.(26)(27)  
In this paper we describe the process of developing, validating and reliability testing the 
DELAY (Delays in EvaLuating Arthritis earlY) questionnaire, which was developed to assess the 
barriers to help seeking at RA onset. This research was undertaken in collaboration with two 
patient research partners who acted as co-facilitators during focus groups, and were involved 
in the analysis and interpretation of qualitative data.  
 
  
Methods 
Integrated approaches were used to develop items for a questionnaire about help seeking 
behaviour at the clinical onset of RA.(28) First, the research team identified potential items 
for inclusion from a synthesis of the literature regarding help seeking behaviour in patients 
with RA.(15) Second, people with a lived experience of RA and joint problems participated in 
focus groups to discuss and further develop the questionnaire item pool and to explore item 
wording and questionnaire structure. During the third phase, focus groups were held with 
healthcare professionals who reviewed the questionnaire for face validity. Finally, we 
undertook a test retest study to assess the reliability and stability of responses to 
questionnaire items.  NHS Research Ethics Committee approval was obtained for this study 
and all participants gave written informed consent. Methods for each of these approaches 
are described below. 
 
1. Initial questionnaire construction  
Initially, 28 questionnaire items were derived from our group’s qualitative interviews with 
people with RA.(13;14) Our systematic synthesis of the qualitative literature (15) regarding 
the barriers to help seeking behaviour at RA onset increased the number of questionnaire 
items to 54. One or more statements were written to represent each concept identified 
from the existing literature. The questionnaire items were organised into themes and a draft 
of the DELAY questionnaire was structured to allow respondents to indicate their agreement 
with each questionnaire item using a five point Likert scale (ranging from strongly disagree 
to strongly agree).  
2. Focus groups to discuss the relevance of potential questionnaire items  
Twenty-three individuals were invited to participate in a series of focus groups to develop 
and validate the individual questionnaire items and the overall presentation of the DELAY 
questionnaire from the perspective of those with a lived experience of RA. Participants were 
recruited from local arthritis charities and patient support groups. Participants were 15 
people diagnosed with  RA, four with other arthritic conditions and four who were related 
to people with RA.  RJS and two Patient Research Partners (IR and ST) co-facilitated the 
focus groups. Focus groups were guided by a topic guide developed by a multidisciplinary 
team (including IR, ST, RS, KR, RH, SHM and KS). The topic guide encouraged participants to 
share and reflect on experiences of help seeking at RA onset. The topic guide also addressed 
whether items should be rephrased, added or removed and to critically appraise the overall 
questionnaire in terms of structure and organisation, comprehensibility, feasibility and 
acceptability.  
 
Three focus groups with 19 healthcare professionals (HCPs) including four consultant 
rheumatologists, two rheumatology trainees, three rheumatology nurse specialists, one 
practice nurse and nine general practitioners were conducted to offer insight into patient 
delay across a range of settings. HCPs were identified though advertisements in local 
rheumatology and academic centres.  
The focus group discussions were digitally audio recorded and transcribed verbatim by RJS. 
Data were analysed using inductive thematic analysis methods.(29)  Initial coding was used 
to generate analytical summaries of accounts. Blind independent initial coding of a sample 
of transcripts was undertaken by RJS and KR. The initial codes were grouped together into 
most noteworthy and frequently occurring categories and related categories were linked 
together using qualitative data analysis software.(30) The themes were reviewed by RJS, KR 
(academics), ST and IR (patient research partners) who discussed changes to be made to the 
questionnaire and individual questions.  
 
3. Test-retest study 
The revised questionnaire was subject to a test-retest survey over two time points to 
establish item stability. Survey participants were patients aged 18 years or above and had 
RA (according to the 2010 ACR/EULAR criteria)(31) or unclassified arthritis (UA).  Ninety-one 
patients with newly presenting RA or UA were approached by the assessing Rheumatologist 
or nurse specialist in secondary care rheumatology clinics. Those who consented were asked 
to complete the DELAY questionnaire and return it using a freepost envelope.  
 
Those who returned their first questionnaire were sent a follow-up copy of the DELAY 
questionnaire; the follow-up was sent approximately two weeks after the first questionnaire 
was returned. If the follow-up questionnaire was not returned within one week of it being 
sent to the participant, one postal reminder was sent. Answers given to questions at baseline 
and follow up were compared using intraclass correlations. This statistic shows how strongly 
the scores given at each time point resemble one another. It was pre-specified that 
statements with correlations which were significant at the 1% level would be classified as 
having good test-retest reliability and the other statements would be considered to have poor 
test-retest reliability.  
 
Findings 
Focus groups with people with a lived experience of RA  
The findings presented here are a summary of how the focus groups were used to inform 
the draft 54 item questionnaire developed from the existing qualitative literature. During 
the focus groups additional items and concepts were proposed, and changes were made to 
the original items. Statements were organised into eight sections (which have been used as 
subheadings below); Experience of symptoms before seeing GP; Reactions to symptom 
onset; Initial self-management of symptoms; Beliefs about the cause of symptoms; Talking 
to others about symptoms; Knowledge about RA before diagnosis; Direct barriers to GP 
consultations (such as personal circumstances or environment) and Communication and 
relationship with GP. This process enhanced the questionnaire’s face validity, and increased 
the number of questionnaire items to 79.  The findings are supported by quotations from 
focus group participants. The revised questionnaire items are presented in table 1.    
 
Section 1. Symptom onset 
Participants agreed that the core symptoms of pain, fatigue, swelling and stiffness were 
covered by the draft DELAY questionnaire, but suggested that the questionnaire should 
refer to “symptoms” as an overarching descriptor, instead of referring to specific symptoms 
(see questions 1 to 7 table 1). For many, fatigue stood out as a prominent symptom, 
therefore, item 8 was dedicated to this issue.  
“This should be major problem not just problem. I have fallen to sleep while driving and I can fall to sleep while 
talking to people, it’s like a switch, a wave of exhaustion. You should change the question.” (Participant with 
RA: Focus group four). 
Participants were keen for the questionnaire to capture the different types of symptom 
onset, and represent the different intensities of symptoms experienced by people at disease 
onset. Questions 1,4,5,6 and 7 were modified from existing statements to create items 
representing the different types of symptom onset.  
“Severity is one of the problems, the onset of the problem, so if the onset is insidious or slow and you may 
ignore it. Obviously if it's very severe and it interfering with their activities of daily living or employment then..... 
they may need to access some sort of health professional as soon as they can suppose”. (Participant with RA: 
focus group five). 
It was highlighted that the proposed methodology was to administer this questionnaire to 
patients at their initial presentation in secondary care. It was also noted that there was 
often considerable delay between initial presentation to the GP and assessment in 
secondary care, therefore it was felt important to emphasise that the time period being 
asked about in the questionnaire was that prior to presentation to the GP. Participants 
suggested that some questions could be subject to misinterpretation, because some items 
asked about symptoms that for many people with RA would be ongoing problems and that 
responses may reflect current symptoms rather than symptoms prior to initial consultation 
with a healthcare provider. 
“I suppose if you’re asking someone if that was something that affected them straight away, you might be able 
to put it in a better way. You could say “did fatigue affect you straight away”. Because people will get confused, 
they will think – I’ve still got fatigue now....So word that differently, so you know, it’s looking for them to say 
that it was only initially.” (Participant with RA: focus group three). 
 Questions were thus changed to emphasise that they were focussed on symptom onset, by 
including words such as “initially” and “first began” (see item 1,2,3,4, 6 and 8). Participants 
also advised that the questionnaire should be introduced by the statement “we would like 
to ask you about your thoughts and feelings at around the time you developed your 
arthritis.” In addition, they suggested that the headings to each section should make clear 
the timeframe that the questions related to.  As a result the following statement was added 
to the introduction to section 1:  “These questions ask about your experience of symptoms 
before you first went to see your GP” and similar headings were added to subsequent 
sections as appropriate.  
 
Section 2. Reactions to symptom onset  
Psychological reactions to the presence of RA symptoms included ignoring symptoms, 
normalising symptoms, carrying on as usual and a “wait and see” approach. Participants 
believed that reactions like these caused people to delay for longer and should be a strong 
feature of the items in section 2.  
“My equivalent is the computer at work and I’d think of my shoulders and it happens to so many people....you 
think oh I have been spending too long on the computer, I ought to do my exercises, I will take some more 
painkillers so you are normalising it.” (Participant with RA: focus group four).  
 
Section 3: Initial self-management of symptoms 
Participants suggested that self-management strategies caused people to delay for longer 
and should feature in the questionnaire, particularly as they may offer symptomatic relief 
but would not be of benefit to long-term disease outcomes.   
“I don't know if you could add this, but some people try to keep moving, or try to sit better at their desk. So.... I 
certainly tried to do things for myself which involved trying to change my behaviour.” (Participant with RA: 
focus group one). 
 
The range of self-management strategies described during the focus groups was broad and 
varied.     
“The usual things are “oh I’ll take some paracetamol”, I’ll try an ice pack or a hot pack” 
“Oh heat pack is another thing that we can put on there”. 
 “Yeah like lavender”. 
 “Oh yeah those bean bags that you can put in the microwave.” 
 “I think a lot of people take cod liver oil, while it’s good it’s not going to do anything for something this major” 
(Participants with RA: focus group three).  
 
Items related to the use of over the counter medications, exercise, diet, seeking advice from 
pharmacists, complementary therapists, other types of healthcare professional and seeking 
spiritual or religious help were discussed. Participants highlighted that the items included in 
this section of the questionnaire should cover a range of possibilities including using 
pharmacies (items 16 & 18), alternative medicines (item 21) and baths (item 27).  
 
Section 4. Beliefs about the causes of symptoms 
Participants discussed the causes they had attributed the early symptoms of RA to, or had 
heard that other people had attributed the initial symptoms of RA to. The causes selected 
for the draft DELAY questionnaire related to beliefs about the causes of symptoms which 
may have influenced help seeking behaviour. Some participants suggested that the 
questionnaire should contain questions which related to the menopause, however, the 
group felt that this was a gender specific issue and concluded that statement which related 
to “hormone changes” would be preferable (item 33). 
RP 7: “Say whether it would be too much of a leading question, should there be a question on the menopause?” 
PRP 3: “I mean you could say, well not to natural causes, but to the menopause, or just generally” getting old. 
PRP 4: “Or hormone levels changing.” (Participant with RA: focus group two). 
Some participants suggested that the questionnaire was less relevant to younger people in 
its current form, and suggested that it should include activities that younger people may 
engage in.  
“Would you consider doing a section for younger people, I mean when you’re younger you don’t really do that 
much house work, so you can’t really attribute it to getting down on the floor and scrubbing the carpet because 
you’re a teenager and you don’t really do that sort of thing. So I guess I would have attributed my symptoms to 
that, I would have attributed it to sport or something like that – if I was a sporty person. So there needs to be 
something along those lines for younger people. So that younger people feel involved in the questions and that” 
(Participant with RA: focus group three).  
 
In response to this, careful consideration was given to the relevance of items to all age 
groups. Some items were changed; for example playing games was included in the following 
question, “At first I thought that my joint symptoms may have been caused by something I 
had been doing (for example at work, during sports, while playing games or around the 
house)” (item 28). 
 Figure 1 illustrates the impact of participant involvement on saturating one section of the 
questionnaire with a range of perspectives on causal beliefs and how they may influence 
patient delay.   
 
Section 5. Speaking to other people and seeking information  
Participants highlighted the positive and negative consequences of speaking to other people 
about symptoms. In some cases, interactions were felt to delay help seeking behaviour.  
“And, so probably it had been two or three weeks like that I had spoken to a friend and they said "Oh yes.....you 
expect to get stiffness and aches and pains". And my ankles my feet were a bit..... were painful.”  (Participant 
with RA: focus group four) 
In addition, it was felt that the internet was also used to find information about symptoms, 
diagnoses and treatment. Therefore, the internet was seen as an alternative to asking other 
people for information before seeking help. The group highlighted that information 
obtained, for example via the internet or by speaking with others, could lead a person to 
seek help, or could cause them to delay for longer, and that questionnaire items should 
reflect both circumstances (see items 41 & 42).   
“So it is another tool that they use, but it can have a negative impact. So an important question maybe if they 
search for information on the internet did it stop them going to see their GP. Because they may have pulled up 
methotrexate and thought, "oh I ain't going". If that's what I've got, then I not going...... going down that 
path.” (Participant with RA: focus group three). 
 
Section 6. Knowledge 
Participants highlighted that many people were unaware that there was more than one type 
of arthritis, and may never have heard of RA.  
“There are people in my family that have or had osteoarthritis but some might have RA. In clinic I was asked if 
there was a family history and I said no but looking back there probably were people in my family with RA.”  
(Participant with RA: focus group five). 
 
Additional items were added to the questionnaire to explore the knowledge that 
participants felt the public had about RA, and the type of knowledge that may help a 
member of the public to be aware of RA, and seek prompt help at the onset of symptoms.  
 
Section 7. Direct barriers and drivers of help seeking  
Participants were encouraged to reflect on additional questions and items to be added to 
the questionnaire. Not being able to carry out everyday activities and the increasing severity 
of symptoms were thought to encourage help seeking.  
“I think some of them do keep trying to go [to the GP], and it affects them quite severely, and there may be a 
reason for them presenting. Because they couldn't go to the gym and couldn't do the five a side football. Or 
whatever.” (Participant with RA: focus group five). 
A question was added about not being able to perform daily activities (item 55). In addition 
to this, three questions were added about the severity of pain (item 56), stiffness (item 57) 
and swelling (item 58).  
 
Participants recognised that in some cases people sought help for very different 
reasons.Participants felt that in some cases people may have been motivated to see the GP 
for an explanation of symptoms, while others may have been driven by the desire for 
symptom relief. Therefore, items 59 to 62 reflected the different reasons participants felt 
would drive someone at the onset of symptoms to help seeking behaviour.  
 “Because you know that there is something really wrong.” (Interviewer: “Was that more important than 
getting treatment?”). “Yeah, because you fearing what it's going to lead to, I mean  am I going to be a cripple 
for the rest of my life?” (Participant with RA: focus group three).  
 
Participants suggested that people with busy lives would be less likely to seek help, 
therefore, a direct barrier to seeking help was a lack of time. This theme was reflected in 
item 62.  
“I think an overriding factor is that people don't have the time. People who are employed are running round 
like, not headless chickens, but the last thing that they worry about is their health because they are more 
interested in earning a living to feed the children and run the car and so on and so. I think the time factor is the 
enemy of you getting information across to people.” (Participant relative of person with RA: focus group one). 
 
Section 8. Communicating with healthcare professionals  
Participants described how some patients did not like visiting their GP; reasons were varied 
including finding it difficult to communicate with the GP and not wanting to waste the GP’s 
time.  
“But I think a lot depends on the relationship with the GP. The patient's belief in their GP. So, some patients 
may be aware that they are viewed as a malingerer, and this may impact on their future help seeking 
behaviour.” (Participant with RA: focus group four) 
 
 In addition it was highlighted that primary care was seen by some as a pressured 
emergency service not appropriate for musculoskeletal complaints. In contrast, it was 
recognised that some individuals were “demanding” in their approach to healthcare and 
were thus more likely to seek help quickly.  
“Getting back to the doctors, if it's not in your nature to be demanding, you know, it's finding the right words to 
say to them.” (Participant with RA: focus group three). 
It was generally felt that some people had a dislike of doctors and thus did not like to visit 
their GP, while other people did not want to bother or inconvenience the doctor.  
“I mean question two “I won’t go to see the doctor if I think I can control it myself”. I think 90% of people would 
rather do it themselves rather than trouble the doctor.” (Participant with RA: focus group five). 
 
Focus groups with Healthcare professionals  
Healthcare professionals were asked to reflect on their experiences of patients consulting 
with the early symptoms of RA, and consider how their experiences mapped on to 
questionnaire items. The quotations below, are examples of the experiences healthcare 
professionals recalled.   
“One of my patients recently, a new RA he had it for about three or four months and he got it in his feet. And 
what he would do every morning is he'd wake up extra early and take is dog out for a walk, an extra along walk 
and the walk got longer and longer and longer, because he said that when he walked his feet felt better. So he 
just carried on and you know.” (Consultant Rheumatologist)  
“The last one I had, had a mother with Rheumatoid. But she had delayed coming because she had a lot of other 
co-morbidities. She had depression. And she had family troubles.”(Rheumatology specialist nurse)  
Healthcare professionals confirmed that the items in the questionnaire were representative 
of their experiences. They also confirmed and discussed the organisation of items into 
sections, and felt that these sections represented core and overarching drivers of patient 
delay.   
 “You’ve got a section on lay sources of information, the internet, the daily mail and sources like that. Definitely 
the internet. Like the health columns in the newspaper.“ (Practice nurse) 
In addition, healthcare professionals recommended three items to be added to the pool 
generated during the previous focus groups with patients and relatives (see items, 25, 30 
and 50).   
“Just general relaxation, mild exercises and just try to take it easy, but it’s not really captured, we could write a 
question about yoga, massage or relaxation people talk about Pilates.” (Consultant rheumatologist)  
 
 “I will add another one, "I think that my condition is stress related". I see patients that think it's work related 
here's another one for you.” (Practice nurse) 
 “The question would be if you think there is a magic cure for something called RA, would you have come 
earlier. As you have said, most people don’t realise that there is a magic cure out there.........Maybe you could 
say....”I didn’t think that there was treatment available”. Or a treatment that needed to be given early.” 
(General practitioner) 
 
Finally, healthcare professionals commented upon the language used in the questionnaire. 
Healthcare professional were concerned that some items may be difficult for patients to 
understand and therefore prone to misinterpretation. Item 11 was changed and the word 
“circumstance” was replaced with “etc” following the statement below.  
“It's just language I mean the first page someone of my age, gender and circumstances. I mean age everyone 
understands, gender - does everyone know what that means? , well... circumstance what does that mean? To 
some people that make sense but to our patients it wouldn't make sense.” (Nurse consultant) 
   
Test-retest findings  
A total of 91 patients were approached to participate, of whom 69 consented and 
completed baseline questionnaires. Forty one of these patients completed the follow up 
questionnaire. The characteristics of responders are shown in table 2.  
Intraclass correlations indicated that the majority of questionnaire items showed good 
reliability over time. Table 1 shows the intraclass correlations and significance level of each 
item. Seven questionnaire items (20, 23, 25, 40, 41, 46 and 61) were deleted due to weak 
intraclass correlations which did not reach a predetermined level of significance of <0.01. 
 
  
Discussion  
We have adopted a mixed approach to the development of the DELAY questionnaire, a tool 
to assess the drivers of and barriers to patient consultation at the onset of RA. This study, 
like others, has demonstrated that people with the lived experience of RA have a valuable 
role to play in the development of research instruments.(27;32) We have described aspects 
of face and content validity and test-retest reliability, and how these were assessed through 
qualitative methods and statistical testing. Participants (including people with the lived 
experience of RA and healthcare professionals) have impacted on questionnaire design by 
adding questions to the item pool, modifying phraseology, determining item relevance and 
organising statements for the questionnaire into eight sections, thus directly influencing 
questionnaire format. Fatigue has previously been recognised by patients as a key attribute 
for patient reported outcome measures for RA.(20) Our study adds to this by suggesting that 
fatigue is an important determinant of help seeking behaviour – the use of this 
questionnaire in prospective studies will assess the extent to which this is so.  
The aim of the questionnaire development process was to generate a large pool of potential 
reasons for patient delay at the onset of RA. The next phase of this research will quantify 
the occurrence of these reasons for delay in a large cohort of people with a new onset of RA 
symptoms. Our current research is using the DELAY questionnaire in a cross-sectional 
sample of people with RA and unclassified arthritis. This questionnaire is used alongside a 
questionnaire completed by a healthcare professional in secondary care (rheumatologist or 
nurse specialist) during the initial contact with the patient. The healthcare professional 
questionnaire captures data on a range of demographic, socioeconomic and disease related 
variables as well as the extent of delay at different time points in the patient’s journey from 
symptom onset to rheumatology assessment. In particular, delays from the onset of 
symptoms of inflammatory arthritis and from the onset of persistent joint swelling are 
captured, in line with recent recommendations from the EULAR study group for risk factors 
for RA.(33)  Relationships between patients’ perspectives on their disease and their 
responses to statements reflecting reasons why they may present quickly or slowly will be 
related to the extents of delay in seeking help to understand in detail the correlates of rapid 
and delayed help seeking. 
 
The DELAY study is ongoing and exploratory factor analysis is planned to identify clusters of 
items which may explain different types of help-seeking behaviour and validation and 
testing in other languages. This is particularly pertinent, as recent data indicate that people 
from South Asian communities delay for longer in seeking help at the onset of RA.(13)  
Translations of this tool, if validated and reliability tested using the methodology presented 
in this paper, can be used to understand the barriers specific to other communities.  In some 
countries including the UK, only half of patients present to a healthcare professional within 
12 weeks of the onset of symptoms attributable to their RA.(11) However in other countries 
including Austria, Germany and the Netherlands delay on the part of the patient is 
shorter.(2;11)  The DELAY questionnaire with validation for use in other countries could be 
used to explore such international differences in reasons for patient delay. 
Lengthy patient delays in seeking help are seen in many other musculoskeletal diseases 
besides RA and in some situations (e.g. patients with ankylosing spondylitis) is much longer 
than in RA.(34) As in RA, long patient delays can lead to poor patient outcomes.(35) The 
DELAY questionnaire provides a template which can be adapted to better understand 
patient delay in other musculoskeletal conditions, where early intervention is beneficial to 
patients.   
 
Conclusion 
 
In collaboration with patients, relatives and a multi-disciplinary team of healthcare 
professionals, we have developed and tested a questionnaire to explore patient delay in 
help seeking for RA. Involvement of people with the lived experience of RA in the 
development of this research tool has led to a more patient oriented measure which 
includes items of most relevance to RA patients’ experiences, and in a format that is 
acceptable for completion. After statistical testing and further feedback from patients, the 
DELAY questionnaire is now being administered in a cross sectional study in order to 
investigate the causes of delay and drivers of help seeking in different demographic groups. 
Data from this study will inform the development of tailored health promotion interventions 
targeted at reducing delay in help seeking for patients with new onset RA. 
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